---
{"dg-publish":true,"permalink":"/research/insights/2025-01-30-15-33-56/","updated":"2025-01-30T15:33:56-05:00"}
---

# Content
- [[Research/Tags/Urolithin A\|Urolithin A]] slows the progression of [[Research/Tags/Intervertebral Disc (IVD)\|Intervertebral Disc (IVD)]] degeneration at a dose of 25 mg/kg/day when taken for 4 weeks after an IVD puncture at 12 weeks of age compared to rats not fed urolithin A
# References
<div><table class="dataview table-view-table"><thead class="table-view-thead"><tr class="table-view-tr-header"><th class="table-view-th"><span>Insights</span><span class="dataview small-text">3</span></th><th class="table-view-th"><span></span></th></tr></thead><tbody class="table-view-tbody"><tr><td><span><a data-tooltip-position="top" aria-label="Research/Insights/2025-01-30 15-35-56.md" data-href="Research/Insights/2025-01-30 15-35-56.md" href="Research/Insights/2025-01-30 15-35-56.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-30 15-35-56</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span><a data-href="Urolithin A" href="Urolithin A" class="internal-link" target="_blank" rel="noopener nofollow">Urolithin A</a> slows the progressive loss of <a data-href="Intervertebral Disc (IVD)" href="Intervertebral Disc (IVD)" class="internal-link" target="_blank" rel="noopener nofollow">Intervertebral Disc (IVD)</a> height at a dose of 25 mg/kg/day when taken for 4 weeks after an IVD puncture at 12 weeks of age compared to rats not fed Urolithin A</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Insights/2025-01-30 15-34-20.md" data-href="Research/Insights/2025-01-30 15-34-20.md" href="Research/Insights/2025-01-30 15-34-20.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-30 15-34-20</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span><a data-href="Urolithin A" href="Urolithin A" class="internal-link" target="_blank" rel="noopener nofollow">Urolithin A</a> slows the progression of <a data-href="Pfirrmann Grade" href="Pfirrmann Grade" class="internal-link" target="_blank" rel="noopener nofollow">Pfirrmann Grade</a> at a dose of 25 mg/kg/day when taken for 4 weeks after an <a data-href="Intervertebral Disc (IVD)" href="Intervertebral Disc (IVD)" class="internal-link" target="_blank" rel="noopener nofollow">Intervertebral Disc (IVD)</a> puncture at 12 weeks of age compared to rats not fed urolithin A</span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Research/Insights/2025-01-30 15-31-32.md" data-href="Research/Insights/2025-01-30 15-31-32.md" href="Research/Insights/2025-01-30 15-31-32.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-30 15-31-32</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span><a data-href="Urolithin A" href="Urolithin A" class="internal-link" target="_blank" rel="noopener nofollow">Urolithin A</a> slows the increase in histologic score at a dose of 25 mg/kg/day when taken for 4 weeks after an <a data-href="Intervertebral Disc (IVD)" href="Intervertebral Disc (IVD)" class="internal-link" target="_blank" rel="noopener nofollow">Intervertebral Disc (IVD)</a> puncture at 12 weeks of age compared to rats not fed urolithin A</span></td></tr></tbody></table></div><div><table class="dataview table-view-table"><thead class="table-view-thead"><tr class="table-view-tr-header"><th class="table-view-th"><span>Original Sources</span><span class="dataview small-text">1</span></th><th class="table-view-th"><span>Citations</span></th></tr></thead><tbody class="table-view-tbody"><tr><td><span><a data-tooltip-position="top" aria-label="Research/Evidence Sources/liuUrolithinInhibitsCatabolic2018.md" data-href="Research/Evidence Sources/liuUrolithinInhibitsCatabolic2018.md" href="Research/Evidence Sources/liuUrolithinInhibitsCatabolic2018.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">liuUrolithinInhibitsCatabolic2018</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="m7.5 4.27 9 5.15"></path><path d="M21 8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16Z"></path><path d="m3.3 7 8.7 5 8.7-5"></path><path d="M12 22V12"></path></svg></a></span></td><td><span>Liu, Huiyong, Honglei Kang, Chao Song, Zuowei Lei, Li Li, Jianfeng Guo, Yong Xu, Hanfeng Guan, Zhong Fang, and Feng Li. “Urolithin A Inhibits the Catabolic Effect of TNFα on Nucleus Pulposus Cell and Alleviates Intervertebral Disc Degeneration in Vivo.” Frontiers in Pharmacology 9 (2018): 1043. <a rel="noopener nofollow" class="external-link" href="https://doi.org/10.3389/fphar.2018.01043" target="_blank">https://doi.org/10.3389/fphar.2018.01043</a>.</span></td></tr></tbody></table></div>

